NCT06118502 A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
| NCT ID | NCT06118502 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Cigarette Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 544 participants |
| Start Date | 2024-03-25 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 544 participants in total. It began in 2024-03-25 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduction product (e-cigarette) for a full 12 weeks. Most participants will receive some combination of these treatments, depending on individual response to each. All visits and study assessments will be entirely remote. All treatments will be provided free of charge for the first 12 weeks. After that, the study team will contact the participants 6 months after the first study phone call to complete another survey. The study lasts six months and will involve 8 surveys.
Eligibility Criteria
Inclusion Criteria: * Smokers who want to quit Exclusion Criteria: * Non-smokers
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06118502 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Cigarette Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06118502 currently recruiting?
Yes, NCT06118502 is actively recruiting participants. Contact the research team at smithtra@musc.edu for enrollment information.
Where is the NCT06118502 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06118502 clinical trial?
NCT06118502 is sponsored by Medical University of South Carolina. The trial plans to enroll 544 participants.